MOLOGEN Lifescience AG operates as an investment company in Germany. It focuses on investments in seed and series A and B company phases, as well as in investment phases in the fields of fintech, blockchain, and related technologies. The company was formerly known as Finchain Capital Partners AG and changed its name to MOLOGEN Lifescience AG in April 2026. MOLOGEN Lifescience AG was founded in 2015 and is headquartered in Düsseldorf, Germany.
0 transactions — 0 buys and 0 sales reported by MOLOGEN Lifescience AG executives.
0 institutional funds report a position on U1DA.F in their latest SEC quarterly filing.
Beyond raw data, we aggregate and score every smart money signal to give you a unique view.
8-dimension composite score: insiders · hedge funds · politicians · momentum · valuation · health · analysts · earnings.
Detection of clustered purchases or sales by several executives in the same stock.
Berkshire, Pershing Square, Tiger Global, Bridgewater and other reporting funds.
NANC & GOP (Pelosi & Republicans), GURU (top hedge funds), ARK (Cathie Wood). See who enters and exits each week.
Spot marked changes in search interest around the stocks being followed.
Create your watchlist and receive a brief of events affecting your tickers.
This public page only shows a preview. The full analysis of U1DA.F on the Kairos Insider dashboard includes:
Free signup · Pro €19/month or €190/year